Article

jdsupra.com on 2017-08-09 21:11

FDA Reauthorization Act Aims to Speed Product Reviews Through User Fee Funding

Congress passes sweeping user fee reauthorization bill to fund increased FDA staffing and support commitments to product review timelines. ...

JD Supra

Related news

Blog: User Fee Reauthorization Picks Up Steam jdsupra.com
President Trump Signs FDA User Fee Reauthorization Bill into Law – A Relief for the Medical Device Industry jdsupra.com
Spalding
FDA User Fee Reauthorization Legislation Enacted by Congress jdsupra.com
Phase 1 , United States , Cures
There'll Be Some Changes Made: President Signs Prescription Drug and Biologic User Fee Reauthorization Act jdsupra.com
User Fee Reauthorization Bill Includes Legislation Proposed to Improve Medical Device Regulation jdsupra.com
FDA Reaches Agreement with Industry for Reauthorization of Medical Device User Fees jdsupra.com
FDA Announces Biosimilar User Fee Rates for FY 2017 jdsupra.com
Congressional Committees Advance Bipartisan FDA User Fee Agreements jdsupra.com
FDA Requests Comments On Product User Fee Programs jdsupra.com
California , United States , Switzerland
FDA User Fee Reauthorization Gains Momentum with Senate HELP Committee Approval jdsupra.com
United Kingdom , Canada , United States
FDA Announces Upcoming Public Meeting on Its Recommendations for Reauthorizing the Biosimilar User Fee Act jdsupra.com
Silver Spring , New Hampshire
FDA User Fee Legislation Moves Forward in Senate with Multiple Policy Riders On-Board jdsupra.com
House Advances Bipartisan FDA User Fee Agreements; Senate Faces Narrow Timeline to Act jdsupra.com
FDA User Fee Reauthorization Legislation Continues to Simmer in Congress: What’s at Stake and What it Means for September jdsupra.com
FDA Reauthorization Act of 2017 passes the House jdsupra.com
Continuing Appropriations Act Includes FDA Reauthorization of User Fees jdsupra.com
Senate HELP Committee Unveils Draft FDA User Fee Reauthorization Legislation, with Major Reforms to In Vitro Diagnostics, Cosmetics and Dietary Supplements jdsupra.com
House Passes FDA Reauthorization Act; Would Reauthorize Key User Fee Programs and Lengthen Medical Device Malfunction Reporting Period for Certain Products jdsupra.com
Manage
FDA Approves Third Biosimilar Product jdsupra.com
New NAD Decision Addresses Product Reviews jdsupra.com